首页> 美国卫生研究院文献>Saudi Journal of Biological Sciences >Tanshinone IIA suppress the proliferation of HNE-1 nasopharyngeal carcinoma an in vitro study
【2h】

Tanshinone IIA suppress the proliferation of HNE-1 nasopharyngeal carcinoma an in vitro study

机译:丹参酮IIA抑制HNE-1鼻咽癌增殖的体外研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nasopharyngeal carcinoma (NPC) at present is considered to be one of the fatal diseases detected commonly in the people belonging to Southeast Asia and southern China. According to the WHO reports among the detected cases of NPC worldwide, 80% are from China. The present study investigates the effect of tanshinone IIA on the migration and invasion potential of HNE-1NPC cells and studied the detailed mechanism involved. Effect of the tanshinone IIA on viability of the HNE-1NPC cells was analyzed by MTS assay. Cell matrigel invasion and wound-healing motility assays, respectively were used for the analysis of invasion and migration potential of HNE-1 cells. Tanshinone IIA inhibited the viability of HNE-1cells in a dose dependent manner. Migration and invasion potential of the tanshinone IIA treated cells was reduced significantly (P < 0.05) compared to the control cells after 48 h. Analysis of the proteins involved in migration and invasion revealed a significant decrease in the expression of matrix metalloproteinase (MMP)-2 and MMP-9 on treatment with tanshinone IIA. It also inhibited the p65 and p50 expression in the nuclear fractions of HNE-1 cells after 48 h. Thus, tanshinone IIA inhibits migration and invasion potential of the HNE-1NPC cells through reduction in the expression of matrix metalloproteinases. Therefore, tanshinone IIA can be used for the treatment of NPC.
机译:目前,鼻咽癌(NPC)被认为是在东南亚和华南地区的人们中普遍发现的致命疾病之一。根据世界卫生组织的报告,在全世界检测到的NPC病例中,有80%来自中国。本研究探讨了丹参酮IIA对HNE-1NPC细胞迁移和侵袭能力的影响,并研究了涉及的详细机制。丹参酮IIA对HNE-1NPC细胞活力的影响通过MTS分析进行了分析。细胞基质胶侵袭和伤口愈合活力测定分别用于分析HNE-1细胞的侵袭和迁移潜能。丹参酮IIA以剂量依赖性方式抑制HNE-1细胞的活力。丹参酮IIA处理的细胞在48小时后的迁移和侵袭潜力与对照细胞相比显着降低(P <0.05)。对涉及迁移和侵袭的蛋白质的分析显示,丹参酮IIA处理后基质金属蛋白酶(MMP)-2和MMP-9的表达显着降低。 48小时后,它还抑制了HNE-1细胞核级分中的p65和p50表达。因此,丹参酮IIA通过减少基质金属蛋白酶的表达来抑制HNE-1NPC细胞的迁移和侵袭能力。因此,丹参酮IIA可用于治疗NPC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号